Storage of volume-reduced washed platelets in M-sol additive solution for 7 days
Article first published online: 4 JUN 2014
© 2014 AABB
Volume 54, Issue 12, pages 3173–3177, December 2014
How to Cite
Hirayama, J., Fujihara, M., Akino, M., Kojima, S., Yanagisawa, R., Homma, C., Kato, T., Ikeda, H., Azuma, H., Shimodaira, S. and Takamoto, S. (2014), Storage of volume-reduced washed platelets in M-sol additive solution for 7 days. Transfusion, 54: 3173–3177. doi: 10.1111/trf.12724
- Issue published online: 11 DEC 2014
- Article first published online: 4 JUN 2014
- Manuscript Accepted: 9 APR 2014
- Manuscript Revised: 7 APR 2014
- Manuscript Received: 21 JAN 2014
Volume-reduced washed platelets (VR-wPLTs), which are prepared by concentrating platelets (PLTs) into a smaller volume of additive solution (AS), may prevent not only circulatory overload, but also adverse reactions caused by plasma components. Although VR-wPLTs may be quickly degraded due to high PLT concentrations, few studies have examined the effects of storage on VR-wPLTs. We examined here the in vitro properties of VR-wPLTs prepared with M-sol AS during their storage for 7 days.
Study Design and Methods
Platelet concentrates (PCs) were divided into two equal aliquots (control group and test group). After the centrifugation of both aliquots and removal of as much supernatant as possible, the pellet of the control group was resuspended in 160 mL of M-sol while that of the test group was resuspended in 80 or 40 mL of M-sol. The wPLTs of both groups were stored in polyolefin bags with agitation at 20 to 24°C for 7 days.
The pH values of both groups were maintained at higher than 7.0 during the 7-day storage. Differences in %disk, CD62P, annexin V, percent hypotonic shock response, and aggregation values between the test group and control group were small for at least 2 days after washing.
The in vitro properties of VR-wPLTs were not markedly degraded for at least 2 days. Therefore, the storage properties of PLTs may be maintained in VR-wPLTs prepared at blood centers until they are administered to patients in hospitals.